147 related articles for article (PubMed ID: 16190752)
1. Pharmacophore modeling, docking, and principal component analysis based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhinovirus coat protein.
Steindl TM; Crump CE; Hayden FG; Langer T
J Med Chem; 2005 Oct; 48(20):6250-60. PubMed ID: 16190752
[TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.
Rollinger JM; Steindl TM; Schuster D; Kirchmair J; Anrain K; Ellmerer EP; Langer T; Stuppner H; Wutzler P; Schmidtke M
J Med Chem; 2008 Feb; 51(4):842-51. PubMed ID: 18247552
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors.
Wang H; Xiao J; Gao D; Zhang X; Yan H; Gong Z; Sun T; Li S
Bioorg Med Chem Lett; 2011 Feb; 21(3):1057-9. PubMed ID: 21215622
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
[TBL] [Abstract][Full Text] [Related]
5. Human rhinovirus 3C protease: generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening.
Steindl T; Laggner C; Langer T
J Chem Inf Model; 2005; 45(3):716-24. PubMed ID: 15921461
[TBL] [Abstract][Full Text] [Related]
6. Parallel screening: a novel concept in pharmacophore modeling and virtual screening.
Steindl TM; Schuster D; Laggner C; Langer T
J Chem Inf Model; 2006; 46(5):2146-57. PubMed ID: 16995745
[TBL] [Abstract][Full Text] [Related]
7. An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Watson KG; Brown RN; Cameron R; Chalmers DK; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell DB; Reece PA; Ryan J; Stanislawski PC; Tucker SP; Wu WY; Barnard DL; Sidwell RW
J Med Chem; 2003 Jul; 46(15):3181-4. PubMed ID: 12852746
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
Krovat EM; Frühwirth KH; Langer T
J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
[TBL] [Abstract][Full Text] [Related]
9. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
10. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.
Wolber G; Langer T
J Chem Inf Model; 2005; 45(1):160-9. PubMed ID: 15667141
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking study of A(3) adenosine receptor antagonists and pharmacophore-based drug design.
Wei J; Li H; Qu W; Gao Q
Neurochem Int; 2009 Dec; 55(7):637-42. PubMed ID: 19540293
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
Kim J; Kim KS; Kim DE; Chong Y
Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
[TBL] [Abstract][Full Text] [Related]
16. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of dioxane-based antiviral agents targeted against the Sindbis virus capsid protein.
Kim HY; Patkar C; Warrier R; Kuhn R; Cushman M
Bioorg Med Chem Lett; 2005 Jul; 15(13):3207-11. PubMed ID: 15927464
[TBL] [Abstract][Full Text] [Related]
18. Modeling the ligand-receptor interaction for a series of inhibitors of the capsid protein of enterovirus 71 using several three-dimensional quantitative structure-activity relationship techniques.
Ke YY; Lin TH
J Med Chem; 2006 Jul; 49(15):4517-25. PubMed ID: 16854057
[TBL] [Abstract][Full Text] [Related]
19. Biological profiling of anti-HIV agents and insight into CCR5 antagonist binding using in silico techniques.
Carrieri A; Pérez-Nueno VI; Fano A; Pistone C; Ritchie DW; Teixidó J
ChemMedChem; 2009 Jul; 4(7):1153-63. PubMed ID: 19544518
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
